10/28: PMTrack2-Patents and Diversity

Expanding Economic Opportunity Through Invention

Moderator: Arlene P. Neal, Neal Blibo, LLP, Washington, DC

Speakers:

• Laurie C. Self, Qualcomm, Washington, DC
• Debodhonyaa (Deb) Sengupta, Dentons US, Washington, DC
• Holly Fechner, Covington & Burling, LLP, Washington, DC

Speakers

• Self, Laurie

  Qualcomm | Senior Vice President and Counsel, Government Affairs

  Laurie Self is Senior Vice President and Counsel of Government Affairs at Qualcomm Incorporated, where she specializes in U.S. and international patent policy issues, including at the intersection of international trade, antitrust and national security laws. Based in Washington, D.C., Ms. Self leads a team that is focused on ensuring that intellectual property laws and policies provide the necessary protections to support the Company’s R&D-driven business model and technology leadership.
• Fechner, Holly

  Covington & Burling LLP | Partner

  Holly Fechner is a Partner at Covington & Burling LLP and Executive Director of Invent Together. Invent Together is dedicated to understanding the gender, race, and other diversity gaps in invention and patenting, and supporting public policy and private initiatives to close them. Nationally ranked by Chambers, Fechner is co-chair of Covington’s technology industry group and received the 2019 American Lawyer Magazine "Dealmaker of the Year" award. Fechner formerly served as Policy Director for Senator Edward M. Kennedy (D-Massachusetts) and Chief Counsel for the Senate Health, Education, Labor & Pensions Committee. She graduated from Oberlin College and received her law degree from the University of Michigan.
• Sengupta, Debodhonyaa (Deb)

  Dentons US | Counsel

  Debodhonyaa Sengupta is Counsel at Dentons US. Debodhonyaa has a doctoral degree in chemistry, and advises clients across the globe on matters related to the preparation and prosecution of domestic and international patent applications, patent infringement and validity opinions, due diligence analyses, and freedom-to-operate analyses in the chemical, pharmaceutical and nanotechnology arts.